Repligen
RGEN
#1859
Rank
C$15.64 B
Marketcap
C$244.80
Share price
2.97%
Change (1 day)
19.76%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2023 (TTM): C$2.82

According to Repligen 's latest financial reports the company's current EPS (TTM) is C-$0.28. In 2022 the company made an earnings per share (EPS) of C$4.74 an increase over its 2021 EPS that were of C$3.30.

EPS history for Repligen from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C$2.82-40.47%
2022C$4.7443.59%
2021C$3.30105.26%
2020C$1.61153.33%
2019C$0.6318.42%
2018C$0.54-47.95%
2017C$1.03108.57%
2016C$0.4920.69%
2015C$0.4116%
2014C$0.35-48.98%
2013C$0.696.52%
2012C$0.65-512.88%
2011C-$0.16-1214.13%
2010C$0.01411-106.25%
2009C-$0.23-200%
2008C$0.23-87.79%
2007C$1.85-2283.33%
2006C-$0.08466-300%
2005C$0.04233-115%
2004C-$0.28-25.93%
2003C-$0.3880%
2002C-$0.21-21.05%
2001C-$0.27-0%
2000C-$0.27-17.39%
1999C-$0.32245.01%
1998C-$0.0940733.33%
1997C-$0.07055-87.18%
1996C-$0.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.07-480.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$26.80-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$12.32-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.38-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C-$0.54 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C-$2.14 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$9.95-3,625.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$1.65-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.54-290.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
C-$6.83 2,320.00%๐Ÿ‡บ๐Ÿ‡ธ USA